Platinum(II)-oxalato complexes of seliciclib (CYC202) derivatives show different cellular effects and lesser adverse effects in mouse lymphoma model than cisplatin

[1]  V. Brabec,et al.  Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin. , 2016, Journal of inorganic biochemistry.

[2]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[3]  Z. Dvořák,et al.  Pharmacological and Molecular Effects of Platinum(II) Complexes Involving 7-Azaindole Derivatives , 2014, PloS one.

[4]  B. Nair,et al.  Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells , 2011, Breast Cancer Research.

[5]  Z. Trávníček,et al.  In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A. , 2011, Journal of inorganic biochemistry.

[6]  Z. Dvořák,et al.  Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: preparation, characterization and in vitro cytotoxicity. , 2010, European journal of medicinal chemistry.

[7]  Z. Dvořák,et al.  Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands. , 2010, Journal of inorganic biochemistry.

[8]  Z. Trávníček,et al.  Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity. , 2010, Journal of inorganic biochemistry.

[9]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[10]  D. Rouillard,et al.  Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines. , 2006, Anticancer research.

[11]  M. Eriguchi,et al.  Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[13]  E. Raymond,et al.  Cellular and molecular pharmacology of oxaliplatin. , 2002, Molecular cancer therapeutics.